awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34246444-20D34178-9A7A-4240-AB79-EBDE952A86D3
Q34246444-20D34178-9A7A-4240-AB79-EBDE952A86D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34246444-20D34178-9A7A-4240-AB79-EBDE952A86D3
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.
P304
Q34246444-20D34178-9A7A-4240-AB79-EBDE952A86D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34246444-20D34178-9A7A-4240-AB79-EBDE952A86D3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dfef17cb42bc9a5d5dbf7570544ea906c7128564
P304
2090-2098
http://www.w3.org/2001/XMLSchema#string